Lagumbay, Nhur Khaleed .

HRN: 26-29-78  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2025
CEFTRIAXONE 1G (VIAL)
01/26/2025
02/01/2025
IV
500 Mg
Q24H
PCAP C
Waiting Final Action 
01/26/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/26/2025
02/01/2025
IV
375 Mg
Q6H
PCAP C
Waiting Final Action 
01/28/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/28/2025
02/03/2025
PO
1.4mL
BID
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: